SavedAdd your journal

Journals / Troia Tıp Dergisi / 2019 / Cilt: 1 - Sayı: 2

RADIATION-INDUCED OPTIC NEUROPATHY

Erkan TOPKAN
Adil ÖZYILKAN
Pages
56–62
Publication Date
2019-08-15
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Present review mainly aims to provide an overview of the currently accessible evidence on pathogenesis, risk factors, and treatment of RION.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Radiation-induced optic neuropathy (RION) is a disabling late complication of radiotherapy leading to irreversible severe visual impairment or even total visual loss which may affect one or both eyes.
📊
Key Findings & Data:Although not fully understood yet, RION is proposed to be a consequence of endothelial and neural cell injury with resultant necrosis.
💡
Conclusion & Impact:Present review mainly aims to provide an overview of the currently accessible evidence on pathogenesis, risk factors, and treatment of RION.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Optic nerves · optic chiasm · risk factors

Abstract

Radiation-induced optic neuropathy (RION) is a disabling late complication of radiotherapy leading to irreversible severe visual impairment or even total visual loss which may affect one or both eyes. Although not fully understood yet, RION is proposed to be a consequence of endothelial and neural cell injury with resultant necrosis. Risk factors include the patient and disease related factors, radiotherapy technique, per fraction and total radiotherapy doses. Currently there is no well-established treatment modality for RION, and usually the various drug therapies fail to reverse the visual loss. Therefore, currently the simplest but most effective treatment of RION is prevention of its occurrence by utilizing more sophisticated radiotherapy techniques and strict adherence to the published dose constraints for optic apparatus. Present review mainly aims to provide an overview of the currently accessible evidence on pathogenesis, risk factors, and treatment of RION.

🔖

Cite This Article

TOPKAN, E., ÖZYILKAN, A. (2019). RADIATION-INDUCED OPTIC NEUROPATHY. Troia Tıp Dergisi, Cilt: 1 - Sayı: 2, 56–62. https://ajindex.com/articles/415749

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Lessell S. Friendly fire: neurogenic visual loss from radiation therapy. J Neuro-ophthalmol 2004;24:243-250
  2. Roden D, Bosley TM, Fowble B, et al. Delayed radiation injury to the retrobulbar optic nerves and chiasm. Clinical syndrome and treatment with hyperbaric oxygen and corticosteroids. Ophthalmology 1990;97:346-351
  3. Lampert PW, Davis RL. Delayed effects of radiation on the human central nervous system: ‘‘Early’’ and ‘‘late’’ delayed reactions. Neurology 1964;14:912-7
  4. Levin LA, Gragoudas ES, Lessell S. Endothelial cell loss in irradiated optic nerves. Ophthalmology. 2000;107(2):370-4
  5. Delanian S, Lefaix JL, Pradat PF. Radiation-induced neuropathy in cancer survivors. Radiother Oncol. 2012;105(3):273-82
  6. Meyer R, Rogers MA, Hornsey S. A reappraisal of the roles of glial and vascular elements in the development of white matter necrosis in irradiated rat spinal cord. Br J Cancer 1986;53:221-3
  7. Hopewell JW, van der Kogel AJ. Pathophysiological mechanisms leading to the development of late radiation-induced damage to the central nervous system. Front Radiat Ther Oncol 1999;33:265-75. 8. van der Kogel AJ. Radiation-induced damage in the central nervous system: An interpretation of target cell responses. Br J Cancer 1986;53:207-17
  8. Kline LB, Kim JY, Ceballos R. Radiation optic neuropathy. Ophthalmology 1985;92:1118-26
  9. Indaram M, Ali FS, Levin MH. In search of a treatment for radiation-induced optic neuropathy. Curr Treat Options Neurol. 2015;17(1):325
  10. Emami B, Lyman J, Brown A, et al: Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 1991;21(1):109-22
  11. Marks LB, Yorke ED, Jackson A, et al: Use of normal tissue complication probability models in the clinic. Int J Radiat Oncol Biol Phys 2010;76(suppl3):S10-S19
  12. Danesh-Meyer HV. Radiation-induced optic neuropathy. J Clin Neurosci. 2008;15(2):95-100
  13. Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta Ophthalmol. 2015;93(5):402-10
  14. Harris JR, Levene MB. Visual complications following irradiation for pituitary adenomas and craniopharyngiomas. Radiology. 1976;120(1):167-71. 16. van den Bergh AC, Schoorl MA, Dullaart RP, et al. Lack of radiation optic neuropathy in 72 patients treated for pituitary adenoma. J Neuroophthalmol. 2004;24(3):200-5
  15. Ove R, Kelman S, Amin PP, Chin LS. Preservation of visual fields after peri-sellar gamma-knife radiosurgery. Int J Cancer. 2000;90(6):343-50.